Latest News - Corporate Lawsuits

Thursday, November 17, 2016 | Business of Medicine, Corporate Lawsuits, Personnel/Company News, Valeant NJ

US Attorney Announces Charges Against Two Executives Tied to Philidor Pharmacy Scheme

The US Attorney’s Office, Southern District of New York has charged two executives in connection with the Philidor Pharmacy scheme that instigated a stock value plunge at Valeant when it was rev…

Read the full story

Monday, January 18, 2016 | Corporate Lawsuits,

Class-Action Suit Against EOS Lip Balm Grows

With their colorful egg-shaped containers, palatable price points ($2.99) and assorted fruity and sweet scents, EOS (which stands for Evolution of Smooth) lip balms have been flying off of store shelv…

Read the full story

Monday, August 10, 2015 | Corporate Lawsuits

Court Rules in Favor of Amarin Corp. in "Off-label" Dispute

Amarin Corporation plc (NASDAQ: AMRN) today announced a United States District Court has ruled that Amarin may promote to healthcare professionals certain uses of Am…

Read the full story

Tuesday, December 17, 2013 | Corporate Lawsuits

Cynosure Announces Successful Settlement of Patent Infringement Lawsuits

Cynosure, Inc. will receive $10 million plus future royalty payments under a comprehensive settlement agreement with Tria Beauty, Inc. that ends the patent infringement litigation between Tria and P…

Read the full story

Tuesday, December 04, 2012 | Corporate Lawsuits

Court: Off-label Drug Promotion Is Protected Speech

The 2nd US Circuit Court of Appeals in New York voted 2-1 to overturn a pharmaceutical salesman's conviction for off-label drug marketing, citing violations against his free speech rights under the Fi…

Read the full story

Tuesday, October 09, 2012 | Corporate Lawsuits

Revance Regains Rights to Its Botulinum Toxins

Revance Therapeutics, Inc. announced a settlement and termination agreement for its contractual relationships with Medicis Pharmaceutical Corporation concerning RT001 Botulinum Toxin Type A Topical Ge…

Read the full story

Friday, September 28, 2012 | Corporate Lawsuits

Pharma Penalties Total $10.2B Over Two Years

Pharmaceutical manufacturers have reached a total of 74 settlements, totaling $10.2 billion in financial penalties with federal and state governments between November 2, 2010 and July 18, 2012. That's…

Read the full story

Wednesday, May 02, 2012 | Corporate Lawsuits

Mylan, Impax Win Ruling in Doryx Generics Patent Case

Mylan Inc. (MYL) said it began selling a generic version of the antibiotic Doryx today after a judge ruled it didn’t infringe a patent held by Warner Chilcott (WCRX) Plc.

Read the full story